LeMaitre Vascular (LMAT)
(Real Time Quote from BATS)
$75.60 USD
+0.60 (0.80%)
Updated May 7, 2024 02:32 PM ET
1-Strong Buy of 5 1
D Value D Growth A Momentum D VGM
Brokerage Reports
0 items in cart
LeMaitre Vascular, Inc. [LMAT]
Reports for Purchase
Showing records 1 - 20 ( 189 total )
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Resuming Coverage - Initiating Coverage
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
We are updating our Healthcare coverage to reflect a recent analyst departure and to drop
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for LMAT 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Medical Technology: Suspending Coverage of 21 Companies
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
1Q23 Recap - Hitting on All Cylinders (Volume/Price)
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S